- Clinical Trials
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 75 Pages
Global
From €1317EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1097EUR$1,250USD£955GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1097EUR$1,250USD£955GBP
- Report
- May 2025
- 136 Pages
Global
From €4169EUR$4,750USD£3,627GBP
- Report
- March 2025
- 139 Pages
Global
From €3510EUR$3,999USD£3,054GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2448EUR$2,789USD£2,130GBP
- Report
- August 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- April 2025
- 150 Pages
Global
From €3379EUR$3,850USD£2,940GBP
€4257EUR$4,850USD£3,704GBP
- Report
- February 2026
- 179 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- March 2023
- 57 Pages
Global
From €2194EUR$2,500USD£1,909GBP
- Report
- September 2023
- 180 Pages
Global
From €4082EUR$4,650USD£3,551GBP
- Report
- September 2024
- 132 Pages
Global
From €6978EUR$7,950USD£6,071GBP

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain.
The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more